Schranz Jennifer 4
4 · Nabriva Therapeutics plc · Filed Nov 2, 2020
Insider Transaction Report
Form 4
Schranz Jennifer
Chief Medical Officer
Transactions
- Tax Payment
Ordinary Shares
2020-10-31$0.50/sh−301$149→ 167,541 total
4 · Nabriva Therapeutics plc · Filed Nov 2, 2020
Ordinary Shares